ABSTRACT OBJECTIVE: The objective of this study was to investigate whether the use of a silver-containing hydrofiber dressing to pack abscess cavity after incision and drainage (I & D) leads to faster wound healing and less pain. METHODS: Patients 18 years or older visiting the emergency department with cutaneous abscesses, requiring I & D, were randomly assigned to the intervention (Aquacel Ag; ConvaTec, Skillman, New Jersey) or standard care (iodoform) group between April 2008 and May 2009. Patients were followed up 48 to 72 hours and 10 to 14 days after the initial visit. Primary outcomes were the proportion of patients with greater than 30% reduction in surface area of abscess or cellulitis at first follow-up. RESULTS: Ninety-two patients were enrolled prospectively and randomly assigned to the Aquacel Ag or the iodoform groups; mean age was 38.0 (SD, 12.0) years; 49 patients were in the Aquacel Ag and 43 were in iodoform groups, respectively. There were no differences in demographic and clinical characteristics between groups. Logistic regression analysis showed that the intervention (Aquacel Ag) was independently associated with greater than 30% reduction in surface area of abscess (P = .002) but not in cellulitis at first follow-up. There was also significant decrease in pain intensity perceived by patients in the Aquacel Ag group based on the mean change in Facial Pain Scale scores between the initial visit and first follow-up. CONCLUSION: In patients with cutaneous abscesses, use of an antimicrobial hydrofiber ribbon dressing for packing was associated with faster wound healing and reduction in perceived pain in comparison with use of iodoform dressing.
This pathogen is also increasingly associated with soft tissue infections requiring incision and drainage (I & D)
. 3 Silver-impregnated hydrofiber dressings have been used effectively to treat burn and surgical wounds in both adult and pediatric populations. 4, 5 A recent in vitro study suggested that silver-donating nanocrystalline dressings were effective in providing a barrier function and antimicrobial activity against epidemic strains of MRSA. 6 The authors hypothesized that use of silver-containing hydrofiber dressing to fill abscess cavity after I & D would lead to enhanced wound healing. The authors chose Aquacel Ag (ConvaTec, Skillman, New Jersey), which is available in ribbon form, to study whether its use in packing abscess cavity after I & D leads to faster wound healing in patients presenting with cutaneous abscessesto theED,compared with use of standardiodoformdressing.
METHODS Setting
This study was conducted in the ED of a 449-bed tertiary care teaching hospital; the ED evaluates approximately 50,000 adult patients and approximately 20,000 pediatric patients annually. The facility is a county hospital near Phoenix, Arizona, and treats a broad range of patients, including a substantial number of poor, transient, and indigent patients. All patients presenting with an SSTI are evaluated and treated at the discretion of the supervising attending physician in the ED. Incision and drainage of an abscess, when indicated, is performed according to standard protocol. The institutional review board of the hospital approved the study.
Subjects
Patients 18 years or older visiting the adult ED with cutaneous abscesses greater than 2 cm in diameter and requiring I & D were eligible and were enrolled prospectively over a 1-year period between May 2008 and April 2009. The rationale for using the 2-cm diameter is based on a previously published study by another group that recommended packing abscesses greater than 5 cm. 7 Patients who were pregnant or nursing or those expecting to become pregnant; patients with known immunodeficiency; those with known hypersensitivity to Aquacel Ag or its components; patients with multiple abscesses or severe systemic manifestations or associated conditions, such as osteomyelitis or septic arthritis; and patients with diabetic foot, decubitus, or ischemic ulcers were excluded from the study. Also, patients who had undergone I & D for the same abscess, had a facial abscess, or expressed their inability to return to the ED or one of the outpatient clinics of the hospital for their first follow-up visit were also excluded. In addition, incarcerated patients and prisoners or those patients who were unable to understand or fully participate in the informed consent process or study protocol, for whatever reason, were considered ineligible for participation in the study.
Randomization
The study protocol was reviewed in its entirety with the ED staff prior to implementation. The resident physician and nurse participating in the patient's care in the ED identified patients eligible for the study and obtained written informed consent. Study participants were randomly assigned to either a ''regular treatment'' group, where the abscess cavity was packed using iodoform packing strips (Kendall, Curity; Tyco Healthcare Group LP, Mansfield, Massachusetts), or an ''intervention group,'' where Aquacel Ag ribbon was placed in the cavity after I & D. Patient group assignment was determined at the time of patient enrollment by referring to consecutive sealed envelopes that had been prerandomized by study personnel using a simple random patient allocation scheme. Patients were instructed to return to the ED or one of the outpatient clinics of the hospital within 48 to 72 hours after the primary visit for their first follow-up. At this time, if repacking was required, the same type of packing material was used to repack the abscess cavity as that of the primary visit. A second follow-up visit was scheduled at 10 to 14 days after the primary visit. The WongBaker FACES Pain Rating Scale, which is a self-report scale, was used for quantitative assessment of pain intensity at the primary and subsequent visits. All pertinent demographic and clinical variables, radiological and laboratory investigations, if any, and measurements of maximal length and width of area of surrounding erythema (cellulitis) and that of the abscess (palpable induration that was verified by remeasuring the actual abscess cavity after drainage) itself were recorded on a standard data collection form.
The primary outcome measures were the proportion of patients with 30% or greater reduction in surface area of the abscess and the proportion of patients with 30% or greater reduction in surrounding cellulitis at the first follow-up visit. In the present study, the 30% or greater reduction in abscess surface area for healing score was derived by a consensus of the treating physicians within the authors' facility and was based on their professional experiences of the patient population specific to that facility. The secondary outcome measure was the change in the reported pain intensity score at the primary and first follow-up visits.
Statistical Analysis
Differences between the Aquacel Ag and iodoform groups for demographic characteristics (age, sex, race/ethnicity) and clinical features (symptom duration, precipitating factors, abscess location, functional impairment, associated comorbidities, history of prior MRSA or treatment failures, and history of MRSA in other family members) were compared using independent-sample t tests for continuous variables and W 2 tests (or Fisher exact test, when appropriate) for categorical variables. To assess difference in pain ratings at different time periods, an analysis of variance (ANOVA) was used with 1 within-subjects factor (time) and 1 between-subjects factor (group: Aquacel Ag vs iodoform). To assess the effect of the intervention on abscess healing and cellulitis healing at the primary visit, the proportions of subjects in each group who experienced a 30% or greater reduction in the affected surface area were compared using Fisher exact test. Based on previously published, controlled, prospective studies, wound area reduction at day 3 with povidone gauze was 15% (the primary outcome in this study). 8, 9 Thus, based on physician consensus and patient demographics in the authors' facility, it was decided that, to be clinically impactful for this investigation, the treatment group should have at least double the rate (30%) of healing at the end of the first follow-up (48Y72 hours). For a Fisher exact test comparing proportions in 2 independent samples of patients randomized to control and treatment groups at a ratio of 1:1 for an > of .05, to achieve a power of at least 80%, a total of 35 patients are required in each group. A multivariate logistic regression analysis was performed to control for the effects of covariates, including age, gender, ethnicity, duration of symptoms, presence of functional impairment, presence of MRSA as the primary pathogen isolated from pus culture, and abnormal vital signs at the primary visit. All statistical analyses were done using SPSS for Windows 15.0 (SPSS Inc, Chicago, Illinois).
RESULTS
A total of 92 patients were found eligible and were enrolled in the study. Their mean age was 38.0 (SD, 12.0) years, and 61 patients (66.3%) were male. A sizable number of patients (39, 42.4%) were of Hispanic origin. Forty-nine patients had been randomly assigned to the intervention (Aquacel Ag) group, and 43 to the regular treatment group (iodoform group). There were no statistically significant differences in demographic or clinical characteristics of patients assigned to either the intervention or the regular treatment groups (Table 1) .
Change in Surface Area of Cellulitis and Abscess
Sixty-eight patients (74%) returned for the first follow-up visit (48Y72 hours). Mean time to first follow-up was 2.4 (SD, 0.92) days.
Of these, 46 patients had follow-up data for abscess available for analysis. Of the Aquacel Ag group, 82.6% of the subjects experienced 30% or greater reduction in abscess area, as compared with 26.1% of the iodoform subjects (P G .0003) at the first follow-up (Table 2A) . In a logistic regression model, none of the variables of age, gender, Hispanic origin, duration of symptoms, and presence of MRSA was predictive of a greater than 30% reduction in surface area of abscesses between the primary and the first follow-up visit. Patients who belonged to the Aquacel Ag group were more likely to experience greater than 30% reduction in surface area of abscess (P = .002); in this model, functional impairment also had a significant impact on the outcome variable (Table 3B) .
Forty-seven patients had complete first follow-up data for cellulitis available for analysis. Of the Aquacel Ag study subjects, 59.1% experienced greater than 30% reduction in surface area of cellulitis compared with 52.0% in the iodoform group; this was not a significant difference (Table 3A) . In the logistic regression model, Hispanic origin was the only variable that was predictive of reduction in surface area of cellulitis between primary and follow-up visits (P = .047). There was no significant effect for this group (Table 3B) .
Improvement in Pain Scores
The ANOVA revealed significant main effects for pain intensity pertaining to the time factor, F 1,63 = 46.23, P G .001, and the group factor, F 1,63 = 4.25, P = .043. There were no significant interaction effects (Tables 4A and B) . Perceived pain decreased significantly from the primary visit to the first follow-up. Patients in the Aquacel Ag group experienced significantly less pain than did those in the iodoform group (Figure 1) .
A total of 42 (45.6%) patients were available for the second follow-up visit between 10 and 14 days; the mean time to follow-up was 11.2 (SD, 6.13) days. At the second follow-up visit, 93% of patients had complete healing of surrounding cellulitis. Independentsample t tests failed to reveal statistically significant differences in the mean surface area of abscess ( Sixteen patients were treated without obtaining a culture from the abscess site. Of the remaining 76 patients from whom culture was obtained, MRSA was the predominant pathogen isolated from 59 patients (77.6%), whereas 17 (22.4%) showed growth of other organisms from the culture site. Plain radiographs were obtained from 6 patients, ultrasound examination was performed on 3 patients, and 2 patients underwent computerized tomographic scans of the affected site. Antibiotics were prescribed to 78 patients (84.8%), and the most commonly prescribed antibiotic was sulfamethoxazole and trimethoprim, which was prescribed to 62 patients (67.4%); 7 patients (7.4%) received clindamycin, 5 patients (5.4%) were prescribed cephalosporin, and parenteral vancomycin was administered to 4 patients (4.3%). A majority of the patients (84, 94.6%) were discharged from the ED following I & D; 5 patients (5.4%) required inpatient admission. There were no refusals to participate. One patient who was initially enrolled had to be subsequently excluded because his abscess did not require packing after I & D. No adverse effects were reported to study personnel from use of Aquacel Ag at the abscess site. At the first follow-up visit, a slightly higher number of patients in the Aquacel Ag group reported that their packing had ''fallen out,'' although this difference was not statistically significant (20% vs 9%, P = .31, Fisher exact). Lack of statistical significance may be a result of insufficient power. This observation was due to fluid absorption by the dressing itself within the wound cavity to form a cohesive gel, resulting in its dissociation from the piece of dressing left outside the cavity, which may have given the erroneous impression to the patient that the entire packing had ''fallen out.'' Since the study, the manufacturer of Aquacel Ag has added fibers to its ribbon to give it additional strength. The study was not designed to analyze the cost between the different procedures, but it did not appear that there was a substantial cost increase when using the Aquacel Ag packing. The iodoform (1/4 inch Â 5 yards packing strips) cost is between $3 and $4, whereas Aquacel Ag ribbon (0.75 Â 18 inches) costs between $9 and $12 each. However, the Aquacel Ag ribbon group needed fewer dressing changes. This does not consider clinician time for the dressing changes or the cost of possible additional pain medications for the iodoform group.
DISCUSSION
As community-acquired MRSA spreads globally, recent studies have noted significant changes in antibiotic-prescribing patterns among emergency physicians for empirical treatment of SSTIs. 10, 11 For simple cutaneous abscesses, however, I & D alone remains the mainstay of treatment, and concomitant antibiotic therapy is recommended only in recurrent and persistent cases where MRSA is strongly suspected. 12 In a recent review of published literature, 14 Whether use of a specific packing material with proven antimicrobial activity against MRSA in vitro after I & D affects the rate of healing of cutaneous abscesses has not been studied previously. In the current study, the authors found that use of Aquacel Ag dressing to pack the abscess cavity after I & D led to faster healing of the abscess and also greater improvement in pain intensity. Improvement in surrounding cellulitis was not impacted by Aquacel Ag use. This study was conducted in a high-MRSA-prevalence area, and the large majority of patients were prescribed antibiotics at discharge. 
